Molecular Quality Controls Market to Witness Steady Growth Through 2036 Amid Rising Demand for Diagnostic Test Accuracy
NEWARK, Del., July 15, 2026 — The global Healthcare industry continues to advance with increasing adoption of precision diagnostics, positioning the Molecular Quality Controls Market as a critical component of laboratory quality assurance and diagnostic accuracy. According to Future Market Insights (FMI), the market is projected to grow from USD 248.2 million in 2026 to USD 479.2 million by 2036, registering a 6.8% CAGR during the forecast period. Growing utilization of molecular diagnostic testing, increasing prevalence of infectious diseases and cancer, expanding genetic testing applications, and stringent regulatory requirements for laboratory quality control are expected to drive sustained market growth worldwide.???? Get Detailed Market Forecasts, Competitive Benchmarking, and Pricing Trends:
https://www.futuremarketinsights.com/reports/sample/rep-gb-14301
The market is anticipated to generate an absolute dollar opportunity of USD 231.0 million between 2026 and 2036. Rising investments in molecular diagnostics laboratories, increasing adoption of PCR and next-generation sequencing (NGS) technologies, and growing emphasis on diagnostic accuracy continue to strengthen global demand for molecular quality control products.
Key Molecular Quality Controls Market Highlights at a Glance
- Market Size (2026): USD 248.2 Million
- Forecast Market Size (2036): USD 479.2 Million
- Forecast Period: 2026–2036
- CAGR (2026–2036):8%
- Absolute Dollar Opportunity: USD 231.0 Million
- Leading Product: Independent Controls (58.0% Market Share)
- Key Growth Regions: USA, UK, EU, Japan, South Korea
- Key Segments Covered: Product, Analyte, Application, Region
- Report Pages: 250
- Last Updated: 2026
- Reviewed by: Anurag Sharma
Why Is the Molecular Quality Controls Market Growing?
The market is expanding steadily as clinical laboratories increasingly prioritize quality assurance and regulatory compliance to ensure the accuracy, consistency, and reliability of molecular diagnostic testing across diverse disease areas.
Key Growth Drivers
- Rising adoption of molecular diagnostic technologies.
- Increasing prevalence of infectious diseases and cancer.
- Growing utilization of PCR and next-generation sequencing (NGS).
- Stringent laboratory quality assurance regulations.
- Expansion of precision medicine initiatives.
- Increasing demand for standardized diagnostic workflows.
- Rising investments in clinical laboratory infrastructure.
- Growing focus on improving diagnostic accuracy.
As molecular testing becomes increasingly important in disease diagnosis and personalized medicine, laboratories continue investing in advanced quality control solutions to maintain high testing standards.
According to Anurag Sharma, Principal Consultant for Healthcare at Future Market Insights, "The growing complexity of molecular diagnostics and expanding use of precision medicine are increasing the need for reliable quality control solutions. Laboratories that implement comprehensive molecular quality assurance programs will be better positioned to deliver accurate, reproducible, and regulatory-compliant diagnostic results throughout the forecast period."
Which Product Segment Leads the Molecular Quality Controls Market?
Independent Controls remain the leading product segment, accounting for 58.0% of the global market in 2026.
Independent quality controls are widely adopted because they enable laboratories to independently verify assay performance, detect testing errors, and ensure compliance with international laboratory standards.
Product Segment Highlights
- Independent controls dominate global product demand.
- Third-party verification improves testing accuracy.
- Supports regulatory compliance across laboratories.
- Enhances confidence in molecular diagnostic results.
Why Is Infectious Disease Diagnostics Driving Market Demand?
Infectious disease diagnostics continue to represent a major application area as laboratories increasingly rely on molecular testing for rapid detection of viral, bacterial, and other infectious pathogens.
Growing demand for accurate and rapid molecular diagnostics continues supporting the widespread adoption of quality control materials.
Application Segment Highlights
- Infectious disease testing drives significant demand.
- Oncology testing supports precision medicine initiatives.
- Genetic testing expands molecular diagnostics adoption.
- Quality controls improve laboratory reliability.
???? Explore the Latest Healthcare Industry Analysis Now:
https://www.futuremarketinsights.com/industry-analysis/healthcare
How Are Clinical Laboratories Supporting Market Expansion?
Clinical laboratories, reference laboratories, and hospital diagnostic centers continue investing in standardized molecular quality control products to improve workflow consistency, regulatory compliance, and patient safety.
Laboratory Highlights
- Clinical laboratories strengthen quality assurance programs.
- Hospital laboratories expand molecular testing capabilities.
- Standardized controls improve workflow consistency.
- Accreditation requirements encourage quality control adoption.
Market Dynamics
Market Drivers
Increasing molecular diagnostics adoption, expanding infectious disease testing, rising cancer diagnostics, growing precision medicine initiatives, stringent laboratory accreditation standards, and technological advancements in molecular testing continue driving global market growth.
Market Restraints
High implementation costs, complex regulatory compliance requirements, limited laboratory budgets in developing regions, and variability across testing platforms continue posing challenges for market participants.
Market Trends
Innovation continues transforming molecular diagnostic quality assurance.
Major trends include:
- Expansion of multiplex molecular testing.
- Growing adoption of next-generation sequencing quality controls.
- AI-assisted laboratory quality management.
- Automated laboratory workflow integration.
- Increased demand for multi-analyte quality controls.
- Rising investment in precision diagnostics infrastructure.
Regional and Country Outlook
North America continues to dominate the global market owing to advanced molecular diagnostics infrastructure, strong laboratory accreditation standards, and widespread adoption of precision medicine.
Europe remains a significant regional market supported by robust healthcare systems, expanding molecular testing programs, and stringent regulatory requirements.
The USA, UK, European Union, Japan, and South Korea continue driving market growth through increasing investments in diagnostic technologies, clinical laboratory modernization, and genomic medicine initiatives.
Asia-Pacific is expected to witness strong growth as healthcare infrastructure expands, molecular diagnostics adoption increases, and governments invest in advanced laboratory capabilities.
Competitive Landscape
Competition remains moderately consolidated, with leading companies focusing on product innovation, regulatory compliance, strategic collaborations, laboratory partnerships, and expansion of molecular quality assurance portfolios.
Key Companies
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific, Inc.
- LGC Limited
- Roche Diagnostics
- Microbiologics, Inc.
???? Read Full Report:
https://www.futuremarketinsights.com/reports/molecular-quality-controls-market
Frequently Asked Questions
- What is the projected size of the Molecular Quality Controls Market by 2036?
The global Molecular Quality Controls Market is projected to reach USD 479.2 million by 2036, growing from USD 248.2 million in 2026.
- What is the expected CAGR of the Molecular Quality Controls Market?
The market is forecast to expand at a 6.8% CAGR between 2026 and 2036.
- Which product segment dominates the market?
Independent Controls lead the market, accounting for 58.0% of total demand in 2026.
- What factors are driving market growth?
Growing adoption of molecular diagnostics, increasing infectious disease and oncology testing, expansion of genetic testing, stringent laboratory quality standards, and rising investments in precision medicine continue driving global market growth.
- Which regions offer the strongest growth opportunities?
The USA, UK, European Union, Japan, and South Korea remain key markets due to advanced laboratory infrastructure, increasing molecular diagnostics adoption, and strong regulatory frameworks.
Related Reports
- Peptide Synthesis Market - https://www.futuremarketinsights.com/reports/peptide-synthesis-market
- Pet Diabetes Care Devices Market - https://www.futuremarketinsights.com/reports/pet-diabetes-care-devices-market
- Pain Management Devices Market - https://www.futuremarketinsights.com/reports/pain-management-devices-market
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie® Award, and a member of the Greater New York Chamber of Commerce) provides deep insights into governing factors elevating demand in global markets.
FMI delivers market intelligence, consulting services, and syndicated research reports across chemicals, materials, food ingredients, pharmaceuticals, industrial manufacturing, sustainability, and advanced materials sectors.
With global expertise and industry-focused research capabilities, FMI provides actionable insights that help organizations understand market dynamics and identify emerging opportunities.
Contact
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware 19713, USA
Rahul Singh
AVP – Marketing and Growth Strategy
Future Market Insights, Inc.
Phone: +91 8600020075
For Sales - [email protected]
For Media - [email protected]
For web - https://www.futuremarketinsights.com/
For Web - https://www.factmr.com/